Cell No. : Cell Name
RCB1148 : TGBC11TKB
update : 2022/07/13
|
| Comment | Japanese gastric cancer, lymph node metastated. Application consideration |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Ohno, T. & Todoroki, T.
|
| Originator |
Kim, B. & Ohno, Tadao
|
| Year of deposit |
1995
|
| Another name |
NaTo
|
| Animal |
human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Race |
Japanese
|
| Gender |
Female
|
| Age at sampling |
72 years
|
| Tissue |
stomach, lymph node meta
|
| Classification |
cancer
|
| Year of origin |
1995
|
|
Lifespan |
infinite
|
| Morphology |
epithelial-like
|
| Cellosaurus(Expasy) |
CVCL_1768
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
| Medium and additives |
|
DMEM (low glucose) + 5% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
pipetting
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
| SC frequency |
|
Subculture : once/week, Medium Renewal : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma |
|
(-)
|
| Virus (HIV) |
|
(-)
|
| Isozyme |
|
LD, NP
|
| Chromosome mode |
|
42-95(50) : 42(5),43(5),44(6),45(11),46(6),47(6)/
|
| STR(human) |
|
OK
|
| Reference information |
Reference |
0
|
| User's Publication |
12
|
| User's Publication |
|
20664
Han Y, Dong Q, Liu T, Chen X, Yu C, Zhang Y.
The novel mechanism of Med12-mediated drug resistance in a TGFBR2-independent manner.
Biochem Biophys Res Commun
2022
610:1-7
PubMed ID: 35461070
|
|
16768
J V, Mishra D, Meher D, Dash S, Besra K, Pattnaik N, Singh SP, Dixit M.
Genetic association of MMP14 promoter variants and their functional significance in gallbladder cancer pathogenesis
J Hum Genet
2021
66(10):947-956
PubMed ID: 33727629
|
|
11511
Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, Santos R, Rao Y, Sassi F, Pinnelli M, Ansari R, Harper S, Jackson DA, McRae R, Pooley R, Wilkinson P, van der Meer D, Dow D, Buser-Doepner C, Bertotti A, Trusolino L, Stronach EA, Saez-Rodriguez J, Yusa K, Garnett MJ.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature
2019
PubMed ID: 30971826
|
|
3734
Cirmi S, Maugeri A, Ferlazzo N, Gangemi S, Calapai G, Schumacher U, Navarra M.
Anticancer Potential of Citrus Juices and Their Extracts: A Systematic Review of Both Preclinical and Clinical Studies.
Front Pharmacol
2017
8:420
PubMed ID: 28713272
|
|
14266
Ducker GS, Ghergurovich JM, Mainolfi N, Suri V, Jeong SK, Hsin-Jung Li S, Friedman A, Manfredi MG, Gitai Z, Kim H, Rabinowitz JD.
Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma
Proc Natl Acad Sci U S A
2017
114(43):11404-11409
PubMed ID: 29073064
|
|
9928
Diaz-Lagares A, Crujeiras AB, Lopez-Serra P, Soler M, Setien F, Goyal A, Sandoval J, Hashimoto Y, Martinez-Cardús A, Gomez A, Heyn H, Moutinho C, Espada J, Vidal A, Paúles M, Galán M, Sala N, Akiyama Y, Martínez-Iniesta M, Farré L, Villanueva A, Gross M, Diederichs S, Guil S, Esteller M.
Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.
Proc. Natl. Acad. Sci. U.S.A.
2016
113:E7535-E7544
PubMed ID: 27821766
|
|
3733
Nishikawaji T, Akiyama Y, Shimada S, Kojima K, Kawano T, Eishi Y, Yuasa Y, Tanaka S.
Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer.
Oncotarget
2016
7(41):67251-67265
PubMed ID: 27572307
|
|
5812
Hirashita Y et al
Reduced phosphorylation of ribosomal protein S6 is associated with sensitivity to MEK inhibition in gastric cancer cells.
Cancer Sci
2016
107(12):1919-1928
PubMed ID: 27699948
|
|
3719
van Haaften G et al
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.
Nat Genet
2009
41(5):521-3
PubMed ID: 19330029
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
|
|
6139
Jin SH, Akiyama Y, Fukamachi H, Yanagihara K, Akashi T, Yuasa Y.
IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells.
Int J Cancer
2008
122(5):1040-6
PubMed ID: 17957782
|
|
1906
Iida S, Akiyama Y, Nakajima T, Ichikawa W, Nihei Z, Sugihara K, Yuasa Y.
Alterations and hypermethylation of the p14(ARF) gene in gastric cancer
Int J Cancer
2000
87(5):654-8
PubMed ID: 10925358
|
Back
Top
CELL BANK Website